603235 天新药业
已收盘 12-19 15:00:00
资讯
新帖
简况
天新药业跌1.06% 2022年上市即巅峰中信证券保荐
中金财经 · 12-08
天新药业跌1.06% 2022年上市即巅峰中信证券保荐
每周股票复盘：天新药业（603235）宁夏项目推进中
证券之星 · 11-09
每周股票复盘：天新药业（603235）宁夏项目推进中
股市必读：天新药业（603235）11月6日披露最新机构调研信息
证券之星 · 11-07
股市必读：天新药业（603235）11月6日披露最新机构调研信息
每周股票复盘：天新药业（603235）股东户数下降10.96%，净利下滑30.15%
证券之星 · 11-02
每周股票复盘：天新药业（603235）股东户数下降10.96%，净利下滑30.15%
图解天新药业三季报：第三季度单季净利润同比下降30.15%
证券之星 · 10-30
图解天新药业三季报：第三季度单季净利润同比下降30.15%
天新药业（603235）披露召开2025年第三季度业绩说明会的公告，10月28日股价下跌0.7%
证券之星 · 10-28
天新药业（603235）披露召开2025年第三季度业绩说明会的公告，10月28日股价下跌0.7%
每周股票复盘：天新药业（603235）取消监事会并修订章程
证券之星 · 09-21
每周股票复盘：天新药业（603235）取消监事会并修订章程
天新药业（603235）披露取消监事会并修订公司章程议案获通过，9月17日股价上涨0.22%
证券之星 · 09-17
天新药业（603235）披露取消监事会并修订公司章程议案获通过，9月17日股价上涨0.22%
每周股票复盘：天新药业（603235）拟取消监事会
证券之星 · 09-14
每周股票复盘：天新药业（603235）拟取消监事会
每周股票复盘：天新药业（603235）宁夏项目一期产能下半年试产
证券之星 · 09-07
每周股票复盘：天新药业（603235）宁夏项目一期产能下半年试产
股市必读：天新药业（603235）9月3日披露最新机构调研信息
证券之星 · 09-04
股市必读：天新药业（603235）9月3日披露最新机构调研信息
每周股票复盘：天新药业（603235）2025年中报净利润同比上升3.14%
证券之星 · 08-31
每周股票复盘：天新药业（603235）2025年中报净利润同比上升3.14%
天新药业(603235.SH)：上半年净利润3.56亿元，同比增长3.14%
格隆汇 · 08-28
天新药业(603235.SH)：上半年净利润3.56亿元，同比增长3.14%
维生素概念盘中跳水，圣达生物跌0.54%
市场透视 · 08-06
维生素概念盘中跳水，圣达生物跌0.54%
维生素概念盘中拉升，华特达因涨6.52%
市场透视 · 08-04
维生素概念盘中拉升，华特达因涨6.52%
天新药业：目前公司维生素D3业务占公司整体收入的比例较小
互动易 · 07-29
天新药业：目前公司维生素D3业务占公司整体收入的比例较小
维生素市场波动加剧 天新药业技术降本成效显著
金融界 · 07-11
维生素市场波动加剧 天新药业技术降本成效显著
天新药业第一季净利增48%，80后总经理余小兵去年领薪135万元、车间主任出身
瑞财经 · 07-10
天新药业第一季净利增48%，80后总经理余小兵去年领薪135万元、车间主任出身
天新药业：股东自愿延长股份锁定期
格隆汇 · 06-27
天新药业：股东自愿延长股份锁定期
天新药业：维生素B1和B6价格高位坚挺 建议关注天新药业
上海申银万国证... · 06-26
天新药业：维生素B1和B6价格高位坚挺 建议关注天新药业
加载更多
公司概况
公司名称：
江西天新药业股份有限公司
所属行业：
食品制造业
上市日期：
2022-07-12
主营业务：
江西天新药业股份有限公司的主营业务是单体维生素研发、生产和销售。公司的主要产品是B族维生素、其他维生素、精细化工品。公司通过了FAMI-QS饲料行业认证，ISO22000、BRC、Halal、Kosher等食品行业认证，以及国内药监部门、欧盟EDQM、美国FDA、日本PMDA等国家制药行业认证，其中维生素B6、维生素B1获得了中国GMP、欧盟CEP证书。
发行价格：
36.88
{"stockData":{"symbol":"603235","market":"SH","secType":"STK","nameCN":"天新药业","latestPrice":27.75,"timestamp":1766127601000,"preClose":27.4,"halted":0,"volume":894100,"delay":0,"changeRate":0.0128,"floatShares":147000000,"shares":438000000,"eps":1.4095,"marketStatus":"已收盘","change":0.35,"latestTime":"12-19 15:00:00","open":27.4,"high":27.93,"low":27.3,"amount":24780500,"amplitude":0.023,"askPrice":27.76,"askSize":123,"bidPrice":27.75,"bidSize":1,"shortable":0,"etf":0,"ttmEps":1.4095,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"adjPreClose":27.4,"symbolType":"stock","openAndCloseTimeList":[[1766107800000,1766115000000],[1766120400000,1766127600000]],"highLimit":30.14,"lowLimit":24.66,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":437780000,"isCdr":false,"pbRate":2.54,"roa":"--","peRate":19.687833,"roe":"9.76%","epsLYR":1.49,"committee":-0.293413,"marketValue":12148000000,"turnoverRate":0.0061,"status":0,"floatMarketCap":4081000000},"requestUrl":"/m/hq/s/603235","defaultTab":"news","newsList":[{"id":"2589313339","title":"天新药业跌1.06% 2022年上市即巅峰中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2589313339","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589313339?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:47","pubTimestamp":1765187224,"startTime":"0","endTime":"0","summary":"中国经济网北京12月8日讯 天新药业 今日收报27.10元，跌幅1.06%。目前该股股价处于破发状态。上市首日，天新药业盘中最高报53.11元，创上市以来股价最高点，此后该股股价震荡走低。天新药业实际募资净额比原拟募资少88,051.06万元。 天新药业本次发行的保荐机构为中信证券，保荐代表人为丁元、方冲。天新药业本次公开发行新股的发行费用合计9737.33万元，其中中信证券获得承销及保荐费用7077.08万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251208/31850935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603235","BK1147","BK1521","LU1997245177.USD","LU1720050803.USD","BK0226","LU2495084118.USD","600030","06030","LU0405327148.USD","BK0028","LU1997245094.SGD","BK0012","LU1655091616.SGD","LU2148510915.USD","LU1064131003.USD","LU1328615791.USD","LU1064130708.USD","LU1997244956.HKD","LU0405327494.USD","BK0276","BK0183","LU1794554557.SGD","LU2289578879.USD","BK0188","BK1564","BK0196","LU1255011170.USD","BK1516"],"gpt_icon":0},{"id":"2582861038","title":"每周股票复盘：天新药业（603235）宁夏项目推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861038?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:26","pubTimestamp":1762633571,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，天新药业报收于27.69元，较上周的27.0元上涨2.56%。本周，天新药业11月7日盘中最高价报28.02元。本周关注点来自机构调研要点：宁夏天新BL、甲醇钠项目正在按计划有序推进。公司董事长已于2025年3月被解除留置，目前公司董事长正常履职，公司生产经营情况正常；期间上市公司未被要求协助调查。目前宁夏天新的募投项目正在按照计划有序推进，后续进展请关注公司公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603235","BK0226"],"gpt_icon":0},{"id":"2581011616","title":"股市必读：天新药业（603235）11月6日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2581011616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581011616?lang=zh_cn&edition=full","pubTime":"2025-11-07 03:05","pubTimestamp":1762455914,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，天新药业报收于27.45元，上涨0.62%，换手率1.03%，成交量1.51万手，成交额4127.87万元。当日关注点来自交易信息汇总：11月6日主力资金净流出42.98万元，散户资金净流入458.71万元。来自机构调研要点：2025年1-9月公司归母净利润同比下滑6.91%，主要因部分维生素产品销量下滑及财务费用正贡献减少。公司董事长已于2025年3月被解除留置，目前公司董事长正常履职，公司生产经营情况正常；期间上市公司未被要求协助调查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700002533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603235","BK0226"],"gpt_icon":0},{"id":"2580470139","title":"每周股票复盘：天新药业（603235）股东户数下降10.96%，净利下滑30.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580470139","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580470139?lang=zh_cn&edition=full","pubTime":"2025-11-02 08:15","pubTimestamp":1762042520,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，天新药业报收于27.0元，较上周的27.18元下跌0.66%。本周，天新药业10月27日盘中最高价报27.28元。天新药业当前最新总市值118.2亿元，在化学制品板块市值排名25/169，在两市A股市值排名1625/5163。业绩披露要点：2025年第三季度归母净利润1.04亿元，同比下降30.15%。股本股东变化股东户数变动截至2025年9月30日，公司股东户数为1.32万户，较6月30日减少1625户，减幅10.96%。公司将于2025年10月31日披露第三季度报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603235","BK0226"],"gpt_icon":0},{"id":"2579148414","title":"图解天新药业三季报：第三季度单季净利润同比下降30.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579148414","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579148414?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:26","pubTimestamp":1761823568,"startTime":"0","endTime":"0","summary":"证券之星消息，天新药业2025年三季报显示，前三季度公司主营收入16.31亿元，同比上升1.08%；归母净利润4.6亿元，同比下降6.91%；扣非净利润4.31亿元，同比下降7.84%；其中2025年第三季度，公司单季度主营收入5.09亿元，同比下降7.02%；单季度归母净利润1.04亿元，同比下降30.15%；单季度扣非净利润9467.55万元，同比下降31.6%；负债率19.36%，投资收益615.57万元，财务费用-2794.23万元，毛利率45.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000039918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603235"],"gpt_icon":0},{"id":"2578296589","title":"天新药业（603235）披露召开2025年第三季度业绩说明会的公告，10月28日股价下跌0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578296589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578296589?lang=zh_cn&edition=full","pubTime":"2025-10-28 22:27","pubTimestamp":1761661640,"startTime":"0","endTime":"0","summary":"截至2025年10月28日收盘，天新药业报收于26.91元，较前一交易日下跌0.7%，最新总市值为117.81亿元。公司近日发布公告称，江西天新药业股份有限公司将于2025年11月6日（星期四）下午16:00-17:00通过上海证券交易所上证路演中心以网络互动方式召开2025年第三季度业绩说明会，就公司经营成果、财务状况等与投资者进行交流。说明会期间，投资者可通过上证路演中心在线参与并提问。公司将于2025年10月31日披露2025年第三季度报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800043250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","603235"],"gpt_icon":0},{"id":"2569467652","title":"每周股票复盘：天新药业（603235）取消监事会并修订章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2569467652","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569467652?lang=zh_cn&edition=full","pubTime":"2025-09-21 04:52","pubTimestamp":1758401533,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，天新药业报收于27.0元，较上周的27.3元下跌1.1%。本周，天新药业9月16日盘中最高价报27.45元。本周关注点公司公告汇总：天新药业召开2025年第一次临时股东大会，审议通过取消监事会并修订《公司章程》的议案。江西天新药业股份有限公司于2025年9月17日召开2025年第一次职工代表大会，选举李全国先生为公司第三届董事会职工代表董事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","603235"],"gpt_icon":0},{"id":"2568977524","title":"天新药业（603235）披露取消监事会并修订公司章程议案获通过，9月17日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568977524","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568977524?lang=zh_cn&edition=full","pubTime":"2025-09-17 23:02","pubTimestamp":1758121341,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，天新药业报收于27.24元，较前一交易日上涨0.22%，最新总市值为119.25亿元。近日，江西天新药业股份有限公司召开2025年第一次临时股东大会，审议通过《关于取消监事会并修订〈公司章程〉及其附件的议案》及《关于修订、制定和废止部分公司治理制度的议案》。其中，《关于取消监事会并修订〈公司章程〉及其附件的议案》作为特别决议事项，获得出席股东所持表决权三分之二以上同意，表决结果为同意347,812,700股，占比99.9372%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700040802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","603235"],"gpt_icon":0},{"id":"2567136734","title":"每周股票复盘：天新药业（603235）拟取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2567136734","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567136734?lang=zh_cn&edition=full","pubTime":"2025-09-14 05:15","pubTimestamp":1757798119,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，天新药业报收于27.3元，较上周的27.47元下跌0.62%。本周，天新药业9月8日盘中最高价报27.75元。本周关注点公司公告汇总：天新药业拟取消监事会，由董事会审计委员会行使监事会职权公司公告汇总：天新药业将修订多项公司治理制度并提交股东大会审议公司公告汇总：天新药业将于2025年9月17日召开第一次临时股东大会公司公告汇总江西天新药业股份有限公司将于2025年9月17日召开第一次临时股东大会，审议两项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","603235"],"gpt_icon":0},{"id":"2565716543","title":"每周股票复盘：天新药业（603235）宁夏项目一期产能下半年试产","url":"https://stock-news.laohu8.com/highlight/detail?id=2565716543","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565716543?lang=zh_cn&edition=full","pubTime":"2025-09-07 05:42","pubTimestamp":1757194938,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，天新药业报收于27.47元，较上周的27.89元下跌1.51%。本周，天新药业9月1日盘中最高价报27.98元。截至2025年6月30日，宁夏天新药业有限公司的总资产为12.47亿元、净资产为1.22亿元，相关募投项目正在按照既定规划稳步推进，预计BL、甲醇钠等产品的一期产能将在下半年逐步试产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","603235"],"gpt_icon":0},{"id":"2564311765","title":"股市必读：天新药业（603235）9月3日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2564311765","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564311765?lang=zh_cn&edition=full","pubTime":"2025-09-04 04:46","pubTimestamp":1756932370,"startTime":"0","endTime":"0","summary":"截至2025年9月3日收盘，天新药业报收于27.17元，下跌0.59%，换手率0.78%，成交量1.15万手，成交额3124.15万元。来自机构调研要点：宁夏天新药业相关募投项目稳步推进，BL、甲醇钠等产品一期产能预计2025年下半年逐步试产。来自机构调研要点：2025年上半年公司实现营业收入11.22亿元，同比增长5.23%；归母净利润3.56亿元，同比增长3.14%。该项目是公司基于下游市场的发展需求，结合公司主营业务和发展战略需要进行的必要性建设，主要产品为BL、甲醇钠等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400003209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603235","BK0226"],"gpt_icon":0},{"id":"2563683628","title":"每周股票复盘：天新药业（603235）2025年中报净利润同比上升3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563683628","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563683628?lang=zh_cn&edition=full","pubTime":"2025-08-31 10:34","pubTimestamp":1756607650,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，天新药业报收于27.89元，较上周的29.84元下跌6.53%。本周，天新药业8月27日盘中最高价报29.92元。本周关注点业绩披露要点：天新药业2025年中报归母净利润3.56亿元，同比上升3.14%。股本股东变化截至2025年6月30日，天新药业股东户数为1.48万户，较3月31日增加349户，增幅2.41%。户均持股数量由3.03万股下降至2.95万股，户均持股市值为80.61万元。2025年第二季度单季度归母净利润1.37亿元，同比下降30.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100003109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603235"],"gpt_icon":0},{"id":"2562085319","title":"天新药业(603235.SH)：上半年净利润3.56亿元，同比增长3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562085319","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562085319?lang=zh_cn&edition=full","pubTime":"2025-08-28 15:36","pubTimestamp":1756366618,"startTime":"0","endTime":"0","summary":"格隆汇8月28日丨天新药业(603235.SH)公布2025年半年度报告，报告期内，公司实现营业收入11.22亿元，同比增长5.23%；归属于上市公司股东的净利润3.56亿元，同比增长3.14%；归属于上市公司股东的扣除非经常性损益的净利润3.36亿元，同比增长2.15%；基本每股收益0.82元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/28153652773684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["603235"],"gpt_icon":0},{"id":"2557403883","title":"维生素概念盘中跳水，圣达生物跌0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557403883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557403883?lang=zh_cn&edition=full","pubTime":"2025-08-06 13:28","pubTimestamp":1754458109,"startTime":"0","endTime":"0","summary":"08月06日，维生素概念盘中跳水，截至13点28分，维生素概念整体指数下跌1.01%，报1753.770点。从个股上来看，该概念的成分股中，圣达生物跌0.54%，兴齐眼药、天新药业、安迪苏跌幅居前。从资金上来看，截止发稿，维生素概念主力净流入为-4.84亿，其中振华股份受到资金热捧，主力净流入4796.55万；拉长时间线来看，该板块近20日主力资金净流入-24.66亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806132829a6d5d834&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806132829a6d5d834&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603079","600299","BK0226","603235","BK0191"],"gpt_icon":0},{"id":"2556487241","title":"维生素概念盘中拉升，华特达因涨6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556487241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556487241?lang=zh_cn&edition=full","pubTime":"2025-08-04 09:42","pubTimestamp":1754271743,"startTime":"0","endTime":"0","summary":"08月04日，维生素概念盘中拉升，截至09点42分，维生素概念整体指数上涨0.75%，报1751.950点。从个股上来看，该概念的成分股中，华特达因涨6.52%，华润三九、梅花生物、天新药业涨幅居前。从资金上来看，截止发稿，维生素概念主力净流入为-4734.36万，其中华润三九受到资金热捧，主力净流入1480.95万；拉长时间线来看，该板块近20日主力资金净流入-21.39亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094223a4733ffc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094223a4733ffc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0226","BK0122","603235","BK0239","BK0175","BK0186","000915","BK0188"],"gpt_icon":0},{"id":"2555331380","title":"天新药业：目前公司维生素D3业务占公司整体收入的比例较小","url":"https://stock-news.laohu8.com/highlight/detail?id=2555331380","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555331380?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:36","pubTimestamp":1753774564,"startTime":"0","endTime":"0","summary":"有投资者向天新药业提问， VD3产品短短一年时间，从60元涨上近200元，请问公司是不有相关产品生产？如果有，年产量是多少吨？公司回答表示，尊敬的投资者您好，目前公司维生素D3业务占公司整体收入的比例较小，具体业务情况请关注公司的定期报告或相关公告。感谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729155055a6c75da8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729155055a6c75da8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603235","BK0226"],"gpt_icon":0},{"id":"2550959594","title":"维生素市场波动加剧 天新药业技术降本成效显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2550959594","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550959594?lang=zh_cn&edition=full","pubTime":"2025-07-11 21:24","pubTimestamp":1752240289,"startTime":"0","endTime":"0","summary":"天新药业股价报27.94元，较前一交易日微跌0.14%。公司所属维生素行业近期呈现明显价格分化，其中维生素D3价格创年内新高，而维生素A、E价格则出现较大幅度回落。作为维生素B1领域的重要生产企业，天新药业与华中药业、兄弟科技共同控制着全球超九成市场份额。公司通过纵向整合实现关键中间体自产，2024年B族维生素毛利率达到49.61%，同比提升7.7个百分点。据测算，维生素B1价格每上涨10元/公斤，可为公司带来约5000万元的净利润增长。风险提示：维生素价格波动较大，行业竞争格局变化可能对公司业绩产生影响。投资者需注意市场风险。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/11212451644307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0226","603235"],"gpt_icon":0},{"id":"2550616106","title":"天新药业第一季净利增48%，80后总经理余小兵去年领薪135万元、车间主任出身","url":"https://stock-news.laohu8.com/highlight/detail?id=2550616106","media":"瑞财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550616106?lang=zh_cn&edition=full","pubTime":"2025-07-10 14:23","pubTimestamp":1752128614,"startTime":"0","endTime":"0","summary":"报告显示，天新药业公司一季度营业收入为6.19亿元，同比增长25.16%；归母净利润为2.19亿元，同比增长48.13%；扣非归母净利润为2.09亿元，同比增长53.30%；基本每股收益0.50元。据东方财富网数据，天新药业总经理余小兵2024年所获薪酬为134.7万元，相较2023年薪酬134.5万元微涨。据天新药业2024年年报，公司2024年营业收入为22.09亿元，同比增长17.35%；归母净利润为6.51亿元，同比增长36.85%；扣非归母净利润为6.14亿元，同比增长42.52%；基本每股收益1.49元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710142348953d161e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710142348953d161e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603235","BK0226"],"gpt_icon":0},{"id":"2546271848","title":"天新药业：股东自愿延长股份锁定期","url":"https://stock-news.laohu8.com/highlight/detail?id=2546271848","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546271848?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:19","pubTimestamp":1751012357,"startTime":"0","endTime":"0","summary":"格隆汇6月27日丨天新药业公布，基于对公司未来持续稳定发展的信心以及对公司价值的认可，公司股东厚鼎投资、厚盛投资、厚泰投资承诺自愿将其所持有的公司首次公开发行前的股份锁定期，自2025年7月11日锁定期满之日起，延长6个月，至2026年1月11日。若因公司送红股、转增股本、配股等原因而导致所持股份数量增加，增加的股份同样遵守上述延长锁定期的承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627162308a4c0af16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627162308a4c0af16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0226","603235"],"gpt_icon":0},{"id":"2546784225","title":"天新药业：维生素B1和B6价格高位坚挺 建议关注天新药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2546784225","media":"上海申银万国证...","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546784225?lang=zh_cn&edition=full","pubTime":"2025-06-26 18:57","pubTimestamp":1750935438,"startTime":"0","endTime":"0","summary":"事件：根据wind 经济数据库显示，2025 年6 月25，公司主力产品维生素B1 价格212.5 元/kg，维生素B6 为162.5 元/kg，价格略有下行，但整体维持高位价格震荡。2024 年B 族维生素收入占营业收入78%比重，公司B 族维生素包括维生素 B6、维生素 B1、叶酸、生物素、维生素B5 等。2025 年上半年，随着下游需求温和复苏、竞争压力初步缓解，B 族维生素行业的景气度有所回升，维生素 B6、维生素 B1 等产品的价格呈现上涨趋势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626185732952c8aa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626185732952c8aa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0226","603235"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766157858991,"stockEarnings":[{"period":"1week","weight":-0.0291},{"period":"1month","weight":-0.0235},{"period":"3month","weight":0.0148},{"period":"6month","weight":0.043},{"period":"1year","weight":0.072},{"period":"ytd","weight":0.0985}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0161},{"period":"3month","weight":0.0147},{"period":"6month","weight":0.1537},{"period":"1year","weight":0.1461},{"period":"ytd","weight":0.1565}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江西天新药业股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"13195人(较上一季度减少10.96%)","perCapita":"11145股","listingDate":"2022-07-12","address":"江西省景德镇市乐平市工业园","registeredCapital":"43778万元","survey":" 江西天新药业股份有限公司的主营业务是单体维生素研发、生产和销售。公司的主要产品是B族维生素、其他维生素、精细化工品。公司通过了FAMI-QS饲料行业认证，ISO22000、BRC、Halal、Kosher等食品行业认证，以及国内药监部门、欧盟EDQM、美国FDA、日本PMDA等国家制药行业认证，其中维生素B6、维生素B1获得了中国GMP、欧盟CEP证书。","listedPrice":36.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"天新药业(603235)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天新药业(603235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天新药业,603235,天新药业股票,天新药业股票老虎,天新药业股票老虎国际,天新药业行情,天新药业股票行情,天新药业股价,天新药业股市,天新药业股票价格,天新药业股票交易,天新药业股票购买,天新药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天新药业(603235)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天新药业(603235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}